VJHemOnc is committed to improving our service to you

ASH 2019 | Venetoclax for elderly ALL?

VJHemOnc is committed to improving our service to you

Daniel DeAngelo

Daniel DeAngelo, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, covers the investigation of venetoclax for acute lymphoblastic leukemia (ALL). He discusses the phase 1 multicenter study of venetoclax with mini-hyper-CVD in older adults with untreated or relapsed/refractory B-ALL and T-ALL. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter